Informações:
Falhas:
ID
34593
Descrição
Phase 2 Study of DS-8500a in Patients With Type 2 Diabetes; ODM derived from: https://clinicaltrials.gov/show/NCT02222350
Link
https://clinicaltrials.gov/show/NCT02222350
Palavras-chave
Versões (1)
- 19/01/2019 19/01/2019 -
Titular dos direitos
see on clinicaltrials.gov
Transferido a
19 de janeiro de 2019
DOI
Para um pedido faça login.
Licença
Creative Commons BY 4.0
Comentários do modelo :
Aqui pode comentar o modelo. Pode comentá-lo especificamente através dos balões de texto nos grupos de itens e itens.
Comentários do grupo de itens para :
Comentários do item para :
Para descarregar formulários, precisa de ter uma sessão iniciada. Por favor faça login ou registe-se gratuitamente.
Eligibility Type 2 Diabetes Mellitus NCT02222350
Eligibility Type 2 Diabetes Mellitus NCT02222350
- StudyEvent: Eligibility
Similar models
Eligibility Type 2 Diabetes Mellitus NCT02222350
- StudyEvent: Eligibility
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de dados
Alias
ID.1
Item
patients aged ≥ 20 years at the time of informed consent
boolean
ID.2
Item
japanese patients with type 2 diabetes
boolean
ID.3
Item
patients who have hba1c ≥ 7.0% and < 10.0% if untreated with antidiabetic agent.
boolean
ID.4
Item
patients who have hba1c ≥ 6.5% and < 9.5% if treated with antidiabetic agent.
boolean
ID.5
Item
patients aged ≥ 70 years at the time of informed consent
boolean
ID.6
Item
patients with a history of type 1 diabetes or diabetic ketoacidosis
boolean
ID.7
Item
patients receiving or requiring treatment with insulin
boolean
ID.8
Item
patients with a body mass index (bmi) of < 18.5 kg/m2 or ≥ 35.0 kg/m2
boolean
ID.9
Item
patients with an estimated glomerular filtration rate (egfr), < 45 ml/min per 1.73 m2
boolean
ID.10
Item
patients with fasting plasma glucose ≥ 240 mg/dl
boolean